
5 June 2025 @ 09:20
Blog: Computational Neoantigen Prediction: Unlocking Personalized Immunotherapy
How somatic variants are computationally translated into candidate neoantigens
5 June 2025 @ 09:20
How somatic variants are computationally translated into candidate neoantigens
12 September 2024 @ 15:27
Dr. Melissa Vrohlings, Translational Science Leader of CDR-Life, shares her experiences with our Virtual Bioinformatics Core service
17 September 2023 @ 14:20
Learn how tumor DNA- and RNA-sequencing enables the discovery of target antigens and response markers for immunotherapies
27 July 2023 @ 13:20
Learn how DNA sequencing data can be analyzed to study the clonal structure and evolution of a tumor.
13 March 2023 @ 09:54
We helped a researcher explore public data to study the biomarker and drug-targed potential of glypicans
6 March 2023 @ 13:18
Learn how a research group used our expertise to study the effects of cancer-predisposing variants
30 September 2022 @ 14:35
Presenting Dr. Flint, the winner of Genevia RNA-Seq Bioinformatics Grant 2022
25 February 2022 @ 11:50
Learn how analyzing mutations sheds light on the biology and treatment of cancer
7 June 2021 @ 14:46
Learn how Genevia Technologies helped Barron Biomedical to identify a target for cancer therapy.
27 May 2021 @ 16:18
Learn how machine learning enables risk stratification using high-throughput data
7 May 2021 @ 09:38
Learn why a pathologist chose Genevia Technologies as their partner.
19 January 2021 @ 10:09
Learn how Genevia Technologies helped uncover prognostic signals from DNA methylation array data